Initially there was no specific way to reverse so um like well um you know um the anticoagulant effect of dabigatran in the event of a uh okay well um like I mean I mean major bleeding event, unlike for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.